Lesson 3. Health Policy Through a Public Health Lens

Headshot of Robert (Bob) Lutz, MD, MPH · Public Health course director
Robert (Bob) Lutz
MD, MPH · Public Health course director
envelope icon
Headshot of Chaise Zozaya, MPH, MBA · Course director
Chaise Zozaya
MPH, MBA · Course director
envelope icon
Table of Contents

Let’s explore how United States health policies shape who gets care, how care is paid for, and what it means for health equity. By viewing policy through a public health lens, we’ll ask not just what works clinically, but what works equitably and systemically. 

The foundations of United States health policy

Note

KFF (Kaiser Family Foundation) is a nonpartisan, data-driven organization that tracks United States health policy, insurance, costs, and access. Students should be familiar with it as a go-to source for clear, timely, and well-contextualized information.

Financing care: Who pays? Who profits? Who’s left out?

Health financing in the United States is a patchwork. Most people are covered through employer-sponsored insurance, but others rely on Medicare, Medicaid, the ACA marketplaces, or are uninsured. 

Key public health concern

Coverage alone doesn’t guarantee access. Insurance networks, cost-sharing, and underinsurance all shape whether care is actually affordable or accessible. 

Use KFF’s resources to learn

The flow of dollars in public vs. private systems. 

The implications of high-deductible plans.

How cost-sharing disproportionately burdens low-income patients.

Try these interactive tools

Health Insurance Coverage in the United States

think about this

How does financing affect population-level outcomes, such as preventive care uptake or chronic disease control?

Access to care: More than insurance

Let’s unpack what “access” really means. Even when people have coverage, they may face: 

policy question

What health system design would reduce these barriers at scale?

public health asks

Who is consistently being left behind, and what systemic barriers are at play?

Examine disparities in access for

• People on Medicaid vs. private plans.
• Non-English speakers.
• Older adults with multiple chronic conditions.

Prescription drug costs: A lens into systemic gaps

Now let’s take a real-world issue—prescription drug affordability—and analyze it through both patient and provider eyes. 

Nearly 4 in 10 Medicare beneficiaries reported skipping or delaying medications due to cost.

Even with insurance, drug prices create financial toxicity, leading to: 

public health framing tip

Focus on population-level consequences: Rising hospitalizations, health disparities, and inefficiency.

think about this

Discuss in Slack: Should the United States allow Medicare to negotiate drug prices? What are the ethical and economic tradeoffs?

Bring it all together: Policy in practice

At this point, you’ve explored the fragmented nature of United States health financing, the gaps in access, the burden of drug costs, and the inequities baked into the system.

Now we shift from analysis to applied public health thinking:

  • How do these issues intersect in the real world?
  • How can policy be used as a lever for population-level change? 

Understanding health policy as a tool for structural change

From a public health standpoint, policy is prevention. It can: 

But policy can also entrench inequities if not designed with equity and access in mind. For example: 

Policy isn’t just about coverage—it's about who gets care, who gets left out, and what outcomes result.

Current policy debates through a public health lens

Let’s walk through some real-time policy issues with a public health mindset. 

  • As of 2025, 10 states have not expanded Medicaid under the ACA.
  • Non-expansion is strongly correlated with: 
    • Higher rates of uninsurance. 
    • Higher preventable mortality (especially among Black adults). 
    • Widening rural hospital closures.

 
Public health lens: Medicaid expansion isn’t just financial—it’s an equity intervention. 

  • The Inflation Reduction Act allows limited price negotiation for high-cost Medicare drugs starting in 2026. 
  • Anticipated outcomes include: 
    • Lower out-of-pocket costs for beneficiaries. 
    • Budget savings for Medicare. 
    • Potential industry backlash or changes in R&D behavior. 

 

Public health lens: Affordable medications lead to better adherence, fewer complications, and reduced strain on emergency services and hospitals.

  • The No Surprises Act (effective 2022) prevents out-of-network charges in emergency situations.
  • Reduces financial shocks but does not address the underlying cost of care. 

Public health lens: One-time protections are a start, but systemic price transparency and equity in billing are needed. 

  • Several states (e.g., Washington, Colorado) have piloted “public option” plans to reduce premiums and expand access.
  • National proposals vary, from strengthening the ACA to creating Medicare-for-All. 

 

Public health lens: The key question isn’t just whether more people are covered—it’s how comprehensively, affordably, and equitably they receive care. 

Apply systems thinking

Think across domains: 

Policy issue Population impact System-level consequences
High drug costs
Medication nonadherence → poorer outcomes, more ER visits
  • Increased hospitalizations
  • Costs
  • Health disparities
Coverage gaps
Delayed or foregone care
  • Preventable death
  • Productivity loss
  • Higher long-term spending 
Cost sharing
Financial strain on low-income patients
  • Widening health inequities
  • Patient distrust 
Surprise bills
Patient financial trauma

Erosion of trust in the system 

think about this

Discuss in Slack (optional): If we designed a health system from scratch using a public health framework, what would it look like, and how would it differ from the one we currently have?

previous

Module 4, Lesson 2

Next

Module 4, Lesson 4